La Jolla Pharma's drug improves kidney function in trial, shares soar

(Reuters) - La Jolla Pharmaceutical Co said its lead experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study, sending the company's shares up about 40 percent in extended trading.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news